- Home
- DSX vs SLS Comparison
DSX vs SLS Comparison
Compare DSX & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSX | SLS |
|---|---|---|
| Founded | 1999 | 2012 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 220.0M | 208.0M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | DSX | SLS |
|---|---|---|
| Price | $1.78 | $2.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 519.5K | ★ 4.5M |
| Earning Date | 11-20-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | ★ 231.99 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $218,560,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $11.40 | N/A |
| P/E Ratio | $11.63 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.27 | $0.77 |
| 52 Week High | $2.04 | $2.48 |
Technical Indicators
Market Signals| Indicator | DSX | SLS |
|---|---|---|
| Relative Strength Index (RSI) | 46.76 | 66.44 |
| Support Level | $1.87 | $1.39 |
| Resistance Level | $2.04 | $2.12 |
| Average True Range (ATR) | 0.08 | 0.15 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 20.00 | 89.45 |
Price Performance
Historical ComparisonAbout DSX Diana Shipping inc. common stock
Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation, the services provided by the vessels are similar and all operate under the same economic environment.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.